TAVR comparable to open heart surgery after 5 years in low-risk patients - report from ACC.25

Michael J. Reardon explains the new five-year data suggest transcatheter aortic valve replacement with a supra-annular, self-expanding valve is a safe and effective alternative to surgical aortic valve replacement when treating low-risk patients. In fact, hemodynamic data after five years consistently favors a transcatheter approach, according to a study presented at the American College of Cardiology’s Annual Scientific Session. Video: https://medicaldigest.org/scientific-contents/interview:tavr-comparable-open-heart-surgery-after-5-years-low-risk-patients